Enovis Corporation

$21.56
USD
Last updated on --.
24h volume1.04M
24h highest22.3900 USD
24h lowest21.3100 USD
24h Price movement-1.73%

ENOV recent prices

24 Hours
-1.73%-$0.38
30 days
-10.43%-$2.515
60 days
-5.07%-$1.155
90 days
-11.85%-$2.905

Key data

Previous close21.9400 USD
Market cap1.31B USD
Volume1.04M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-19.7600 USD
Net income (FY)-1.13B USD
Revenue (FY)2.28B USD
Last report dateMay 7, 2026

About Enovis Corporation

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
HeadquartersWILMINGTON
Employees (FY)7.80K
Revenue per employee (FY)292.02K USD
Net income per employee (FY)-145.42K USD
Listed onNew York Stock Exchange
Official website

ENOV conversion tables

ENOVENOV
USDUSD
0.5 ENOV10.78 USD
1 ENOV21.56 USD
5 ENOV107.8 USD
10 ENOV215.6 USD
USDUSD
ENOVENOV
0.5 USD0.023191 ENOV
1 USD0.046382 ENOV
5 USD0.23191 ENOV
10 USD0.46382 ENOV

FAQ

ENOV is trading at $21.56, -1.73% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ENOV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ENOV is currently trading at $21.56, -1.73% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ENOV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ENOV's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ENOV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ENOV's historical range and other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector.
Enovis Corporation's market cap is currently 1.31B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.04M
24h highest22.3900 USD
24h lowest21.3100 USD
24h Price movement-1.73%
ENOVENOV
USDUSD
Start trade with ENOV Perpetual